Safety and efficacy of everolimus in Asian patients with metastatic renal cell carcinoma (mRCC) who failed previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy: A subanalysis of REACT.
Sun Young Rha
No relevant relationships to disclose
Se-Hoon Lee
Consultant or Advisory Role - Bayer; Novartis; Pfizer
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer
Expert Testimony - Bayer; Novartis; Pfizer
Yen-Chuan Ou
No relevant relationships to disclose
Jin-Hee Ahn
No relevant relationships to disclose
Yen-Hwa Chang
No relevant relationships to disclose
Vichien Srimuninnimit
No relevant relationships to disclose
Ho Yeong Lim
No relevant relationships to disclose
Ik-Joo Chung
No relevant relationships to disclose
See-Tong Pang
No relevant relationships to disclose
Hong-Ling Xue
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Ashok Panneerselvam
Employment or Leadership Position - Novartis
Jooseop Chung
No relevant relationships to disclose
Chee-Keong Toh
No relevant relationships to disclose